Induction of amyloid precursor protein by the neurotoxic peptide, amyloid‐beta 25–35, causes retinal ganglion cell death

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Neurochemistry

• Publication date

  2010-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1471-4159.2010.06724.xPMID 20374419
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell biology, regulation and inhibition of β‐secretase (BACE‐1)

  2009cited by this paper
• Bmc Complementary and Alternative Medicine Comparison of Bee Products Based on Assays of Antioxidant Capacities

  2009cited by this paper
• Comparison of Alzheimer Aβ(1–40) and Aβ(1–42) amyloid fibrils reveals similar protofilament structures

  2009cited by this paper
• Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury

  2009cited by this paper
• Recharacterization of the RGC-5 retinal ganglion cell line.

  2009cited by this paper
• Soluble amyloid beta oligomers may contribute to apoptosis of retinal ganglion cells in glaucoma.

  2008cited by this paper
• Gamma-secretase inhibition and modulation for Alzheimer's disease.

  2008cited by this paper
• Reduced retinal function in amyloid precursor protein‐over‐expressing transgenic mice via attenuating glutamate‐N‐methyl‐d‐aspartate receptor signaling

  2008cited by this paper
• Oxidative and nitrative stress markers in glaucoma.

  2008cited by this paper
• Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-β-Mediated Cortical Synaptic Dysfunction

  2008cited by this paper
• Active and passive immunotherapy for neurodegenerative disorders.

  2008cited by this paper
• Intracellular amyloid beta-protein as a therapeutic target for treating Alzheimer's disease.

  2008cited by this paper
• Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein.

  2008cited by this paper
• DNA damage-inducing agents elicit γ-secretase activation mediated by oxidative stress

  2008cited by this paper
• CHIP and HSPs interact with β-APP in a proteasome-dependent manner and influence Aβ metabolism

  2007cited by this paper
• CHIP and HSPs interact with beta-APP in a proteasome-dependent manner and influence Abeta metabolism.

  2007cited by this paper
• Intracellular amyloid-β in Alzheimer's disease

  2007cited by this paper
• Targeting amyloid-beta in glaucoma treatment.

  2007cited by this paper
• Oxidative stress activates a positive feedback between the γ‐ and β‐secretase cleavages of the β‐amyloid precursor protein

  2007cited by this paper
• Alpha-secretase as a therapeutic target.

  2007cited by this paper
• Targeting amyloid-β in glaucoma treatment

  2007cited by this paper
• Intracellular amyloid-beta in Alzheimer's disease.

  2007cited by this paper
• Involvement of ER stress in retinal cell death

  2007cited by this paper
• Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway

  2007cited by this paper
• Elevated neprilysin activity in vitreous of patients with proliferative diabetic retinopathy.

  2006cited by this paper
• Kinase-dependent differentiation of a retinal ganglion cell precursor.

  2006cited by this paper
• The various aggregation states of beta-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression.

  2006influential reference
• High frequency of open-angle glaucoma in Japanese patients with Alzheimer's disease.

  2006cited by this paper
• Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.

  2006cited by this paper
• [S2‐01‐01]: Alpha‐secretase as a therapeutic target

  2005cited by this paper
• Vitreous fluid levels of β-amyloid(1–42) and tau in patients with retinal diseases

  2005cited by this paper
• The prevalence of primary open-angle glaucoma in Japanese*1The Tajimi Study

  2004cited by this paper
• Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid beta precursor protein.

  2004influential reference
• Regulation of β‐amyloid precursor protein expression by brain‐derived neurotrophic factor involves activation of both the Ras and phosphatidylinositide 3‐kinase signalling pathways

  2004cited by this paper
• The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study.

  2004cited by this paper
• Regulation of amyloid precursor protein expression and secretion via activation of ERK1/2 by hepatocyte growth factor in HEK293 cells transfected with APP751.

  2003cited by this paper
• Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene.

  2002cited by this paper
• Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension.

  2002cited by this paper
• High Occurrence Rate of Glaucoma among Patients with Alzheimer’s Disease

  2002cited by this paper
• Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease.

  2002cited by this paper
• Regulation of Promoter Activity of the APP Gene by Cytokines and Growth Factors

  2002cited by this paper
• β-Amyloid Activates the Mitogen-Activated Protein Kinase Cascade via Hippocampal α7 Nicotinic Acetylcholine Receptors:In Vitro and In Vivo Mechanisms Related to Alzheimer's Disease

  2001influential reference
• Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.

  2001cited by this paper
• Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition

  2000cited by this paper
• Reply to: 'Clearance of amyloid β-peptide from brain: transport or metabolism?'

  2000cited by this paper
• Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma.

  1999cited by this paper
• The Phosphatidylinositol 3‐Kinase Inhibitor Wortmannin Alters the Metabolism of the Alzheimer's Amyloid Precursor Protein

  1999cited by this paper
• Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study.

  1998cited by this paper
• Amyloid beta-protein(25-35) increases cellular APP and inhibits the secretion of APPs in human extraneuronal cells.

  1997cited by this paper
• Amyloid β-Protein25-35Increases Cellular APP and Inhibits the Secretion of APPs in Human Extraneuronal Cells

  1997influential reference
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

  1996influential reference
• Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma.

  1996cited by this paper
• RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

  1996cited by this paper
• Amyloid β‐Protein Induces Its Own Production in Cultured Degenerating Cerebrovascular Smooth Muscle Cells

  1995cited by this paper
• Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells.

  1995cited by this paper
• Prevalence of glaucoma. The Beaver Dam Eye Study.

  1992cited by this paper
• The prevalence of glaucoma.

  1981cited by this paper

• Retinal and Vascular Findings in Optical Coherence Tomography in Healthy Cognitive Patients With Alzheimer Disease Biomarkers

  2025cites this paper
• Elevated Neurodegeneration Markers in the Aqueous Humor of Primary Open Angle and Normal Tension Glaucoma Patients Correlate With Disease Severity

  2025cites this paper
• Klotho null mutation leads to retinal degeneration characterized by functional impairment, gliosis, and deposition of amyloid-beta and hyperphosphorylated tau proteins

  2025cites this paper
• Retinal Alterations as Potential Biomarkers of Structural Brain Changes in Alzheimer’s Disease Spectrum Patients

  2023cites this paper
• Herbal Mixture of Carthamus tinctorius L. Seed and Taraxacum coreanum Attenuates Amyloid Beta-Induced Cognitive Dysfunction In Vivo

  2022cites this paper
• Retinal imaging in Alzheimer’s disease

  2021cites this paper
• Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline.

  2021cites this paper
• Neurocognitive Assessment and Retinal Thickness Alterations in Alzheimer Disease: Is There a Correlation?

  2020cites this paper
• Neuroprotective effects of brain‐derived neurotrophic factor against amyloid beta 1‐40‐induced retinal and optic nerve damage

  2019cites this paper
• Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis.

  2019cites this paper
• Spectral Domain-Optical Coherence Tomography Measurements inAlzheimer’s Disease: A Systematic Review andMeta-analysis

  2019cites this paper
• Alpha-Linolenic Acid from Perilla frutescens var. japonica Oil Protects Aβ-Induced Cognitive Impairment through Regulation of APP Processing and Aβ Degradation.

  2017cites this paper
• Pharmacologic Therapy of Ocular Disease

  2017cites this paper
• Analysis of the Interleukin-6 (-174) Locus Polymorphism and Serum IL-6 Levels with the Severity of Normal Tension Glaucoma

  2017cites this paper
• Ocular indicators of Alzheimer’s: exploring disease in the retina

  2016cites this paper
• Translational Pharmacology in Glaucoma Neuroprotection.

  2016cites this paper
• Carnosic Acid Prevents Beta-Amyloid-Induced Injury in Human Neuroblastoma SH-SY5Y Cells via the Induction of Autophagy

  2016cites this paper
• MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD).

  2015cites this paper
• Dementia of the eye: the role of amyloid beta in retinal degeneration

  2015cites this paper
• Amyloid-beta mediates the receptor of advanced glycation end product-induced pro-inflammatory response via toll-like receptor 4 signaling pathway in retinal ganglion cell line RGC-5.

  2015cites this paper
• Tissue kallikrein (kallidinogenase) protects against retinal ischemic damage in mice.

  2014cites this paper
• Interleukin-6(-174) Locus Polymorphism and Serum IL-6 Levels in Normal Tension Glaucoma

  2014cites this paper
• Mild Endoplasmic Reticulum Stress Promotes Retinal Neovascularization via Induction of BiP/GRP78

  2013cites this paper
• Glaucoma and Alzheimer’s Disease – Common Pathomechanisms and Therapeutic Measures

  2013cites this paper
• Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease.

  2013cites this paper
• Annatto prevents retinal degeneration induced by endoplasmic reticulum stress in vitro and in vivo.

  2012cites this paper
• An investigation into pro-apoptotic targets in experimental glaucoma and the neuroprotective effects of Ginkgo biloba in retinal ganglion cells

  2012cites this paper
• An investigation into the combined effects of β-amyloid toxicity and cerebral ischemia on the pathological expression of gangliosides.

  2012influential citation
• The role of amyloid-β in retinal degeneration.

  2012cites this paper
• Axonal protection via modulation of the amyloidogenic pathway in tumor necrosis factor-induced optic neuropathy.

  2012cites this paper
• Egr1 expression is induced following glatiramer acetate immunotherapy in rodent models of glaucoma and Alzheimer's disease.

  2011cites this paper
• Liquiritigenin attenuates the learning and memory deficits in an amyloid protein precursor transgenic mouse model and the underlying mechanisms.

  2011cites this paper
• Involvement of Bid and caspase‐2 in endoplasmic reticulum stress‐ and oxidative stress‐induced retinal ganglion cell death

  2011influential citation
• Glaucoma and Alzheimer's disease in the elderly

  2011cites this paper
• Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25–35 or Aβ1–40 peptide in rats

  2010cites this paper